Pilot study of FOLFOX or XELOX Therapy Versus FOLFOX or XELOX + PSK Therapy as Postoperative Adjuvant Therapy for Histological Stage IIIa and IIIb Colon Cancer

Phase 4

• Conditions: Colon cancer

• Registration Number: JPRN-UMIN000006134
• Lead Sponsor: Tokai University School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-09
• Study Completion: 2012-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patient with metachronous or synchronous cancer 2.Patient who requires continuous use of phenytoin or warfarin potassium 3.Patient who has experienced serious drug allergy over grade 3 in the past 4.Patient with serious complications including paralysis of intestine, ileus, interstitial pneumonitis, fibroid lung, uncontrollable diabetes mellitus, heart insufficiency, renal insufficiency or hepatic insufficiency 5.Patient who is pregnant or in lactation, or wish to become pregnant during this study 6.Male patient who intends to make someone pregnant during this study 7.Patient with HIV positive 8.Patient who is judged to be inappropriate as subject to this study by the principal investigator or the doctors in charge

Study & Design

• Study Type: Interventional
• Study Design: Not specified